Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-06-09
1989-04-18
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 13, 546 90, 546141, 546142, A61K 3147, C07D21724
Patent
active
048228001
ABSTRACT:
Substituted 3-isoquinolinol compounds of the general formula ##STR1## that exhibit cardiotonic, renal vasodilating and phosphodiesterase fraction III properties are pharmacologically active in the treatment of cardiac conditions. Methods for synthesizing and using those compounds are described.
REFERENCES:
patent: 2538341 (1951-01-01), Ullyot
patent: 2640829 (1953-06-01), Wilson, III et al.
patent: 3627469 (1971-12-01), Cheng
patent: 3716542 (1973-02-01), Lenaers et al.
patent: 4409017 (1983-10-01), Serban et al.
Blomquist, et al., "Chemical Abstracts", vol. 56, 1962, col. 7225b.
Bell, et al., "Chemical Abstracts", vol. 62, 1965, col. 1632d.
Bellas, et al., "Chemical Abstracts," vol. 62, 1965, col. 1632d.
Popov, et al., "Chemical Abstracts," vol. 82, 1975, col. 140009c.
McKillop, et al., "Chemical Abstracts.," vol. 88, 1978, col. 88:50620q.
Falotico Robert
Kanojia Ramesh M.
Press Jeffery B.
Tobia Alfonso J.
Lambert Benjamin F.
Ortho Pharmaceutical Corporation
Raymond Richard L.
Turnipseed James H.
LandOfFree
Isoquinolinol compounds having cardiotonic and phosphodiesterase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isoquinolinol compounds having cardiotonic and phosphodiesterase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoquinolinol compounds having cardiotonic and phosphodiesterase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2397133